Non-small cell lung cancer (NSCLC) Clinical Trials in Pittsburgh, PA

As of June 2026, 41 paid clinical trials are recruiting for Non-small cell lung cancer (NSCLC) in Pittsburgh, Pennsylvania. Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 3, 2026.

Related specialties in Pittsburgh

Oncology· 485 Lung oncology· 54

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

41 clinical trials for Non-small cell lung cancer (NSCLC)

·Clear filters·↓ Download CSV

Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

for Non-small Cell Lung Cancer (NSCLC)

1 location in Pittsburgh

Sponsor: Olivera Finn

Sex: All·Age: 18+

Code: NCT01720836·Phase 1, Phase 2·Recruiting

Apply to this trial